Stifel Maintains Solventum(SOLV.US) With Buy Rating, Maintains Target Price $82
Solventum Initiated at Buy by Stifel
Stifel Initiates Solventum(SOLV.US) With Buy Rating, Announces Target Price $82
Goldman Sachs Adjusts Price Target on Solventum to $55 From $54
Solventum Analyst Ratings
Piper Sandler Initiates Solventum(SOLV.US) With Hold Rating, Announces Target Price $71
BofA Securities Maintains Solventum(SOLV.US) With Hold Rating
Bank of America Securities Keeps Their Hold Rating on Solventum Corporation (SOLV)
Solventum Analyst Ratings
BTIG Initiates Solventum(SOLV.US) With Hold Rating
Wells Fargo Maintains Solventum(SOLV.US) With Hold Rating, Maintains Target Price $64
Maintaining Hold on Solventum Corp: Weighing Transformation Progress Against Near-Term Financial Headwinds
Solventum Analyst Ratings
Goldman Sachs Maintains Sell on Solventum, Raises Price Target to $54
Solventum Analyst Ratings
Bank of America Securities Reaffirms Their Hold Rating on Solventum Corporation (SOLV)
Analysts' Opinions Are Mixed on These NA Stocks: Solventum Corporation (SOLV) and CG Oncology, Inc. (CGON)
Wells Fargo Maintains Solventum(SOLV.US) With Hold Rating, Announces Target Price $69
Hold Rating on Solventum Corporation Amidst Uncertain Growth and Strategy Execution
Solventum Analyst Ratings